Skip to main content

Diabetes mellitus: the success pathway of stem cell therapy

Image
By

Currently, healthcare system is facing variety of challenges globally; finding an effective diabetes treatment is one of them. Diabetes is the simplest version of the metabolic diseases with very remote risk factors; which are yet to be pinpointed. The symptoms of this mysterious disease can be controlled but cannot be cured completely. However, the promises made by science of regenerative medicines and stem cells, have given a new hope to the medical fraternity.       


        

Stem cells are the unique precursor cells of the body, with the great potential to differentiate into variety of cells, on demand. This property of stem cells can as well be applied to the diseases like diabetes, wherein human body is in crisis of insulin producing beta cells; more commonly known as the pancreatic cells. This facet of regenerative medicine has sparked great interest in many scientists in order to achieve a hallmark therapy for diabetes with the help of stem cells.

What is Diabetes?

Diabetes is a common form of autoimmune, metabolic disorders. The human body requires energy, to perform various complicated functions such as breathing, digestion, etc. The energy is acquired through carbohydrates or more precisely though glucose molecules. These glucose molecules are being released into the blood from food via certain digestive juices. In order to transport this glucose into the cells; a vehicle is required, which is known to be the insulin. This insulin is produced by the beta cells of pancreas.In type 2 diabetes, the insulin is either not produced by the pancreatic beta cells or it cannot utilize the glucose molecules; whereas in case of type 1 diabetes, pancreatic beta cells are damaged due to autoimmunity.

Conventional Treatments

Currently, there is as such no cure available for diabetes. However, type 2 diabetes can atleast be managed with the consumption of some of the medicines, healthy diet and regular exercise; on the contrary, type 1 diabetes cannot be controlled unless and until some hormonal supplements are being taken. If left untreated for the longer period of time, high blood sugar can cause serious damage to heart, eyes, kidneys, etc. Thus, an alternative, ambitious treatment, such as stem cell therapy can be opted to manage the disease symptoms and to reduce the hormonal dependency.

With the recent advancements of technology and science, it is now possible to isolate stem cells from various potential sources; both autologous as well as allogenic. In case of autologous sources, bone marrow and adipose tissues are known to be the best available choices, for obtaining hematopoietic and mesenchymal stem cells. Similarly, allogenic mesenchymal stem cells can as well be availed; if in case, the higher number is suggested for infusion. These cells are processed under controlled conditions, to get enriched in viability and concentration and then can be infused back into the body. The most trusted route, in case of diabetes patients is local infusion; directly into the pancreas. Once inside the body, these cells are known to proliferate and differentiate into desired pancreatic beta cells to restore the lost function back.

Various clinical data, is suggesting that with the application of stem cells treatment and with the implementation of ideal route of administration, the symptoms of diabetes can be managed with reduced insulin dependency.

For more information about various technology updates and news visit our site Technology Blog Hub

Comments

Post a Comment

Popular posts from this blog

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age

By
The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age   The field of regenerative medicine reached a remarkable milestone recently when four women regained full sexual function after the successful implantation of lab-grown vaginas created from their own cells. The women, aged thirteen to eighteen, were born with a rare medical condition called Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS) which left them with an abnormal or missing vagina. Each woman underwent a newly engineered procedure that involved taking samples of the patient's own cells and growing them into tissue. This tissue was then placed on a scaffold that was hand-sewn with collagen-like fibers and uniquely shaped to fit each woman’s vaginal cavity. Once the organ fully matured, it was implanted into a canal in each woman’s pelvis, along with the hand-sewn scaffolding. Within six months, the biodegradable scaffolding dissolved and, in each of the four women, the lab-grown vaginas began fun...
Post a Comment
Read more

Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS

By
 Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS At least 40 cases of mucormycosis, also known as black fungus, have been reported from Surat in Gujarat among those who have recovered from Covid-19. Of the 40, eight have lost their eyesight. What is this infection and who is more vulnerable? Cases of mucormycosis, commonly known as black fungus, have been reported from Gujarat among those who have recovered from Covid-19. The number of such cases has increased as Gujarat sees an exponential rise in coronavirus infections. At least eight persons were reported to have lost their eyesight in Surat due to mucormycosis (MM) after recovering from Covid-19. They had to be admitted to hospitals for the sudden loss of vision. In the past 15 days, Surat has reported at least 40 cases of mucormycosis or black fungus including eight who have lost their eyesight. The infection, triggered by Covid-19, is treatable but if left untreated or if the treatment is ...
Post a Comment
Read more

US Moves to Shut Down 2 Big Stem Cell Therapy Clinics

By
Federal authorities Wednesday moved to shut down two of the country’s most prominent for-profit providers of stem cell therapy, one of them a network of clinics with more than 100 offices in the United States, including several in the Bay Area. The Food and Drug Administration filed two complaints in federal court requesting permanent injunctions that would stop Florida-based U.S. Stem Cell Clinic and the California Stem Cell Treatment Center from marketing therapies. Both companies have previously been called out by the FDA for providing unproven, unapproved therapies that could put patients at risk. The injunction requests are an aggressive move by the FDA to patrol the consumer stem cell market. The agency has come under mounting pressure by scientists and patient advocates to increase oversight of the growing consumer market, which has been allowed to flourish for years. “In the two cases filed today, the clinics and their leadership have continued to disregard th...
Post a Comment
Read more